NFKB1 and metabolic disease: An excess of ANGPTL2 causes chronic inflammation by activating NF-κB inflammatory signalling through integrin α5β1 [38] and irreversible tissue remodelling associated with the progression of metabolic diseases, such as obesity, type 2 diabetes, and atherosclerosis [39].